Thomas Kaley, MD, PharmD

Rare Disease / Clinical Research

Memorial Sloan Kettering Cancer Center

SHOREWOOD, IL

PI on 7 trialsNPI: 1730203704

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Anaplastic oligodendroglioma
Anaplastic astrocytoma
Meningioma
Gliosarcoma
Hemangioblastoma
Subependymoma

Clinical trials (7)

NCT00498927
NCT00589784
NCT01392209
NCT00588523
NCT03220646
NCT01892397
NCT06934889

Verify independently

ClinicalTrials.gov PI search for Thomas Kaley, MD
NPPES NPI registry entry

Other specialists for Anaplastic oligodendroglioma

Peers ranked by clinical-trial PI role, publications, and verification quality.

Maryam Fouladi, MD
COG Phase I Consortium
OH
Annick Desjardins, MD, M.D
Duke Health
NC
Patrick Y Wen, MD
National Cancer Institute (NCI)
MA
Jana Portnow, MD
City of Hope Medical Center
CA
Katherine E Warren, M.D.
National Cancer Institute (NCI)
Debra N Yeboa, MD
M.D. Anderson Cancer Center
TX
Patrick Wen, MD, MD
National Cancer Institute (NCI)
MA
Ernest C. Borden, MD
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

See all specialists for Anaplastic oligodendroglioma →

← Back to specialists directory